Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years

Identifieur interne : 001F04 ( PascalFrancis/Corpus ); précédent : 001F03; suivant : 001F05

Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years

Auteurs : Naheed L. Khan ; Wagner Horta ; Louise Eunson ; Elizabeth Graham ; Janel O. Johnson ; SHANNON CHANG ; Mary Davis ; Andrew Singleton ; Nicholas W. Wood ; Andrew J. Lees

Source :

RBID : Pascal:05-0262070

Descripteurs français

English descriptors

Abstract

We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 20
A06       @2 4
A08 01  1  ENG  @1 Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years
A11 01  1    @1 KHAN (Naheed L.)
A11 02  1    @1 HORTA (Wagner)
A11 03  1    @1 EUNSON (Louise)
A11 04  1    @1 GRAHAM (Elizabeth)
A11 05  1    @1 JOHNSON (Janel O.)
A11 06  1    @1 SHANNON CHANG
A11 07  1    @1 DAVIS (Mary)
A11 08  1    @1 SINGLETON (Andrew)
A11 09  1    @1 WOOD (Nicholas W.)
A11 10  1    @1 LEES (Andrew J.)
A14 01      @1 Department of Molecular Neuroscience, Institute of Neurology @2 Queen Square, London @3 GBR @Z 1 aut. @Z 3 aut. @Z 4 aut. @Z 7 aut. @Z 9 aut. @Z 10 aut.
A14 02      @1 Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara @2 Fortaleza, Ceara @3 BRA @Z 2 aut.
A14 03      @1 Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health @2 Bethesda, Maryland @3 USA @Z 5 aut. @Z 6 aut. @Z 8 aut.
A14 04      @1 Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School @2 London @3 GBR @Z 10 aut.
A20       @1 479-484
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000124582390130
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 18 ref.
A47 01  1    @0 05-0262070
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C02 03  X    @0 002B17A03
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Parkine @5 02
C03 02  X  ENG  @0 Parkin @5 02
C03 02  X  SPA  @0 Parkin @5 02
C03 03  X  FRE  @0 Porteur @5 03
C03 03  X  ENG  @0 Carrier @5 03
C03 03  X  SPA  @0 Portador @5 03
N21       @1 185
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 05-0262070 INIST
ET : Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years
AU : KHAN (Naheed L.); HORTA (Wagner); EUNSON (Louise); GRAHAM (Elizabeth); JOHNSON (Janel O.); SHANNON CHANG; DAVIS (Mary); SINGLETON (Andrew); WOOD (Nicholas W.); LEES (Andrew J.)
AF : Department of Molecular Neuroscience, Institute of Neurology/Queen Square, London/Royaume-Uni (1 aut., 3 aut., 4 aut., 7 aut., 9 aut., 10 aut.); Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara/Fortaleza, Ceara/Brésil (2 aut.); Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health/Bethesda, Maryland/Etats-Unis (5 aut., 6 aut., 8 aut.); Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School/London/Royaume-Uni (10 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 4; Pp. 479-484; Bibl. 18 ref.
LA : Anglais
EA : We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.
CC : 002B17; 002B17G; 002B17A03
FD : Système nerveux pathologie; Parkine; Porteur
ED : Nervous system diseases; Parkin; Carrier
SD : Sistema nervioso patología; Parkin; Portador
LO : INIST-20953.354000124582390130
ID : 05-0262070

Links to Exploration step

Pascal:05-0262070

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years</title>
<author>
<name sortKey="Khan, Naheed L" sort="Khan, Naheed L" uniqKey="Khan N" first="Naheed L." last="Khan">Naheed L. Khan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Horta, Wagner" sort="Horta, Wagner" uniqKey="Horta W" first="Wagner" last="Horta">Wagner Horta</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara</s1>
<s2>Fortaleza, Ceara</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eunson, Louise" sort="Eunson, Louise" uniqKey="Eunson L" first="Louise" last="Eunson">Louise Eunson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graham, Elizabeth" sort="Graham, Elizabeth" uniqKey="Graham E" first="Elizabeth" last="Graham">Elizabeth Graham</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Janel O" sort="Johnson, Janel O" uniqKey="Johnson J" first="Janel O." last="Johnson">Janel O. Johnson</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Shannon Chang" sort="Shannon Chang" uniqKey="Shannon Chang" last="Shannon Chang">SHANNON CHANG</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Davis, Mary" sort="Davis, Mary" uniqKey="Davis M" first="Mary" last="Davis">Mary Davis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0262070</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0262070 INIST</idno>
<idno type="RBID">Pascal:05-0262070</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001F04</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years</title>
<author>
<name sortKey="Khan, Naheed L" sort="Khan, Naheed L" uniqKey="Khan N" first="Naheed L." last="Khan">Naheed L. Khan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Horta, Wagner" sort="Horta, Wagner" uniqKey="Horta W" first="Wagner" last="Horta">Wagner Horta</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara</s1>
<s2>Fortaleza, Ceara</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eunson, Louise" sort="Eunson, Louise" uniqKey="Eunson L" first="Louise" last="Eunson">Louise Eunson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graham, Elizabeth" sort="Graham, Elizabeth" uniqKey="Graham E" first="Elizabeth" last="Graham">Elizabeth Graham</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Janel O" sort="Johnson, Janel O" uniqKey="Johnson J" first="Janel O." last="Johnson">Janel O. Johnson</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Shannon Chang" sort="Shannon Chang" uniqKey="Shannon Chang" last="Shannon Chang">SHANNON CHANG</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Davis, Mary" sort="Davis, Mary" uniqKey="Davis M" first="Mary" last="Davis">Mary Davis</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Singleton, Andrew" sort="Singleton, Andrew" uniqKey="Singleton A" first="Andrew" last="Singleton">Andrew Singleton</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Carrier</term>
<term>Nervous system diseases</term>
<term>Parkin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Parkine</term>
<term>Porteur</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>20</s2>
</fA05>
<fA06>
<s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>KHAN (Naheed L.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>HORTA (Wagner)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>EUNSON (Louise)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GRAHAM (Elizabeth)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>JOHNSON (Janel O.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>SHANNON CHANG</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DAVIS (Mary)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>SINGLETON (Andrew)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>WOOD (Nicholas W.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>LEES (Andrew J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Molecular Neuroscience, Institute of Neurology</s1>
<s2>Queen Square, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara</s1>
<s2>Fortaleza, Ceara</s2>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20>
<s1>479-484</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000124582390130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0262070</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Parkine</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkin</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkin</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Porteur</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Carrier</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Portador</s0>
<s5>03</s5>
</fC03>
<fN21>
<s1>185</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 05-0262070 INIST</NO>
<ET>Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years</ET>
<AU>KHAN (Naheed L.); HORTA (Wagner); EUNSON (Louise); GRAHAM (Elizabeth); JOHNSON (Janel O.); SHANNON CHANG; DAVIS (Mary); SINGLETON (Andrew); WOOD (Nicholas W.); LEES (Andrew J.)</AU>
<AF>Department of Molecular Neuroscience, Institute of Neurology/Queen Square, London/Royaume-Uni (1 aut., 3 aut., 4 aut., 7 aut., 9 aut., 10 aut.); Hospital Universitario Walter Cantidio, Neurology Service and Movement Disorders Department, Federal University of Ceara/Fortaleza, Ceara/Brésil (2 aut.); Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health/Bethesda, Maryland/Etats-Unis (5 aut., 6 aut., 8 aut.); Reta Lila Weston Unit of Neurological Studies, Royal Free Hospital and University College Medical School/London/Royaume-Uni (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 4; Pp. 479-484; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>We report on a large Brazilian kindred with young-onset parkinsonism due to either a homozygous or heterozygous mutation in parkin. A total of 6 members were affected: 5 were homozygous and 1 heterozygous for a deletion in exon 4. Two other heterozygotes also had extra-pyramidal signs. All affected subjects showed characteristic features of parkin disease with foot dystonia and an excellent response to levodopa complicated by motor fluctuations and dyskinesia within 3 years of therapy. Careful clinical follow-up over 10 years showed the phenotype was similar in all the homozygotes with asymmetrical limb bradykinesia and early walking difficulties. Some acceleration of disability was observed in some of the cases as they entered the third decade of illness, but dementia was absent.</EA>
<CC>002B17; 002B17G; 002B17A03</CC>
<FD>Système nerveux pathologie; Parkine; Porteur</FD>
<ED>Nervous system diseases; Parkin; Carrier</ED>
<SD>Sistema nervioso patología; Parkin; Portador</SD>
<LO>INIST-20953.354000124582390130</LO>
<ID>05-0262070</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F04 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001F04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0262070
   |texte=   Parkin disease in a brazilian kindred : Manifesting heterozygotes and clinical follow-up over 10 years
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024